An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder

被引:15
|
作者
Ellis, Laura Peyton [1 ]
Parlier-Ahmad, Anna Beth [2 ]
Scheikl, Marjorie [3 ,4 ]
Martin, Caitlin E. [3 ,4 ,5 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[2] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA
[3] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA
[4] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA
[5] 1101 East Marshall St,11th Floor,Room 11-027,Box 9, Richmond, VA 23298 USA
关键词
addiction; integrated care; opioid use disorder; postpartum; pregnancy; ASSISTED TREATMENT; WOMEN; DEPENDENCE; RETENTION; OUTCOMES;
D O I
10.1097/ADM.0000000000001052
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
ObjectivesPerinatal opioid use disorder is increasing. Integrated obstetric/addiction care models likely optimize parent-infant dyad outcomes, but the ideal combination of services is unknown. This study (1) describes pregnancy-to-postpartum service utilization by people receiving buprenorphine at an integrated Obstetric/Addiction Clinic and (2) explores the association between service utilization and postpartum buprenorphine continuation.MethodsThis retrospective medical record review study uses research registry data from an outpatient Obstetric/Addiction Clinic. All patients are invited to participate in the research registry. For patients who consent, monthly medical record abstractions are conducted beginning with their first clinic visit to collect demographic, obstetric, and substance use disorder treatment variables. Present analyses included patients who delivered an infant between June 2019 and June 2021, started buprenorphine during pregnancy, and were receiving buprenorphine at delivery. Overall service utilization was the number of services (range 0-12) used between 28-weeks gestation and 12-weeks postpartum. Bivariate analyses and multivariable logistic regression assessed associations between service utilization and buprenorphine continuation.ResultsParticipants (n = 42) were primarily non-Latinx White (67%) with comorbid psychiatric diagnoses (95%). On average, participants used 6 services; prenatal care, mental health care, and postpartum contraception were most utilized. Overall, 69% of participants continued buprenorphine at 6 months postpartum. This did not differ by level of service utilization (bivariate [P = 0.07], multivariable [P = 0.16]).ConclusionIntegrated care with a harm reduction focus supports pregnancy-to-postpartum service utilization and buprenorphine continuation in a patient sample at high risk for medication for opioid use disorder discontinuation. Further work is needed to identify evidence-based methods to individualize integrated obstetric/addiction care.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [31] Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder
    Krans, Elizabeth E.
    Kim, Joo Yeon
    James, Alton Everette, III
    Kelley, David
    Jarlenski, Marian P.
    OBSTETRICS AND GYNECOLOGY, 2019, 133 (05): : 943 - 951
  • [32] Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder
    Jennifer D. Ellis
    Chung Jung Mun
    David H. Epstein
    Karran A. Phillips
    Patrick H. Finan
    Kenzie L. Preston
    Neuropsychopharmacology, 2022, 47 : 1836 - 1843
  • [33] Mindfulness-Based Relapse Prevention with Individuals Receiving Medication-Assisted Outpatient Treatment for Opioid Use Disorder
    Zullig, Keith J.
    Lander, Laura R.
    Sloan, Samantha
    Brumage, Michael R.
    Hobbs, Gerry R.
    Faulkenberry, Laurel
    MINDFULNESS, 2018, 9 (02) : 423 - 429
  • [34] Medication Treatment of Adolescent Opioid Use Disorder in Primary Care
    Carney, Brittany L.
    Hadland, Scott E.
    Bagley, Sarah M.
    PEDIATRICS IN REVIEW, 2018, 39 (01) : 43 - 45
  • [35] Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder
    Ellis, Jennifer D.
    Mun, Chung Jung
    Epstein, David H.
    Phillips, Karran A.
    Finan, Patrick H.
    Preston, Kenzie L.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (10) : 1836 - 1843
  • [36] Mindfulness-Based Relapse Prevention with Individuals Receiving Medication-Assisted Outpatient Treatment for Opioid Use Disorder
    Keith J. Zullig
    Laura R. Lander
    Samantha Sloan
    Michael R. Brumage
    Gerry R. Hobbs
    Laurel Faulkenberry
    Mindfulness, 2018, 9 : 423 - 429
  • [37] CARE AND TREATMENT RECOMMENDATIONS FOR Pregnant Women WITH OPIOID USE DISORDER
    Reising, Virginia A.
    Bergren, Martha Dewey
    Bennett, Amanda
    MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2019, 44 (04) : 212 - 218
  • [38] Maternity Care for Pregnant Women with Opioid Use Disorder: A Review
    Rizk, Abigail H.
    Simonsen, Sara E.
    Roberts, Leissa
    Taylor-Swanson, Lisa
    Lemoine, Jennifer Berkowicz
    Smid, Marcela
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2019, 64 (05) : 532 - 544
  • [39] Training for integrated care treatment of Opioid use disorder
    Bhat, Christine Suniti
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2019, 19
  • [40] Marijuana, Opioid, and Alcohol Use Among Pregnant and Postpartum Individuals Living With HIV in the US
    Yee, Lynn M.
    Kacanek, Deborah
    Brightwell, Chase
    Haddad, Lisa B.
    Jao, Jennifer
    Powis, Kathleen M.
    Yao, Tzy-Jyun
    Barr, Emily
    Broadwell, Carly
    Siminski, Suzanne
    Seage, George R., III
    Chadwick, Ellen G.
    JAMA NETWORK OPEN, 2021, 4 (12)